Categories: CancerNews

OMI Pulse is now an ASCO Recognized Quality Solution data provider for ASCO Certified – a program helping to deliver patient-centered care

JERSEY CITY, N.J., Sept. 30, 2025 /PRNewswire/ — OMI Pulse recently received recognition as a recognized quality solution for pathway utilization data for ASCO Certified. Achieving this recognition demonstrates OMI’s commitment to data quality. ASCO Recognized Quality Solution (RQS) enables our oncology practices to more easily submit pathway utilization data for ASCO Certified—creating a frictionless experience for our health system and oncology practice partners.

OMI Pulse is an available pathway program reviewed and deemed appropriate for use in the ASCO Certified program based on the “ASCO Criteria for High-Quality Clinical Pathways in Oncology”. 

“Providing physicians point of care decision support that meets ASCO criteria for high quality clinical pathways in Oncology is extremely important,” said Dr. Andrew Pecora, CEO & Chairman of Outcomes Matter Innovations. “It will allow physicians using OMI technology to make cancer care more affordable for their patients while maintaining the highest level of quality.”

A commitment to data quality

ASCO RQS identifies technology and data providers that offer quality data products and resources to oncology practices. Through this recognition, oncology practices have a reliable and easy way to comply with ASCO Certified data requirements. 

Becoming a RQS data provider

OMI Pulse underwent a rigorous validation process reviewing necessary data elements for clinical quality measurement and pathway utilization signal a commitment to data quality. 

To apply to become an ASCO RQS data provider and to receive resources, contact cdr@asco.org [Attn: Recognized Quality Solution]

About Outcomes Matter Innovations 

Outcomes Matter Innovations, LLC (OMI) is a New Jersey-based company focused on supplying specialty physicians with real-time decision support technology at the point of care combined with a novel reimbursement model to enable value-based care programs intended to maintain or improve clinical quality outcomes and significantly reduce cost of care.

Founded in 2018, OMI is expanding nationally, working with multiple and varied specialty physicians to develop clinical treatment pathways to embed in its technology for conditions which have a high total cost of care and high variability in cost to improve clinical outcomes and significantly reduce unnecessary care variation and total cost of care.

About RQS

RQS offers data providers the ability to submit data for pathways for practices. The RQS program provides data vendor(s) with a unique opportunity to demonstrate their commitment to data quality or compliance and streamline the certification processes for OMI’s practices.

About ASCO Certified

ASCO Certified is ASCO’s flagship certification program featuring the ASCO and COA Oncology Medical Home standards and certifies outpatient oncology group practices and health systems that meet a single set of comprehensive standards for patient-centered care. The program enables practices to review quality, outcomes, and utilization measures from electronic health records, insurance claims, patient satisfaction surveys, and evidence-based treatment pathways.

Contact: 
Alison Brown
860-965-9009
akarp218@gmail.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/omi-pulse-is-now-an-asco-recognized-quality-solution-data-provider-for-asco-certified–a-program-helping-to-deliver-patient-centered-care-302571348.html

SOURCE Outcomes Matter Innovations, LLC

Staff

Recent Posts

Lightera Advances Fiber-integrated Temperature Feedback for Safer Laser-based Medical Procedures

SAN FRANCISCO, Jan. 16, 2026 /PRNewswire/ -- BiOS - Hall D Booth #8430, Photonics West Hall…

12 hours ago

DiagnosTear Announces Interim Clinical Results Indicating High Efficiency from TeaRx(TM) Red Eye

Vancouver, British Columbia--(Newsfile Corp. - January 16, 2026) - DiagnosTear Technologies Inc. (CSE: DTR) (FSE:…

17 hours ago

NuGen Medical Devices Provides 2025 Year End Update on R&D and Strategic Progress

Toronto, Ontario--(Newsfile Corp. - January 16, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen"…

18 hours ago

University of Phoenix and LinkedIn to host webinar on AI in nursing with skills and strategies for a new era of healthcare

January 22 virtual event "AI in Action: Skills and Strategies for a New Era of…

18 hours ago

Instinct Science Acquires ScribbleVet to Deliver the Next Generation of Intelligent-Native Veterinary Practice Management Software

The combination redefines PIMS by embedding AI, workflow, and clinical intelligence into a single system…

18 hours ago

Hemostemix Receives FDA Support for Its Basket Protocol Approach

Calgary, Alberta--(Newsfile Corp. - January 16, 2026) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE:…

23 hours ago